To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
News
Researchers from SHFJ and DMTS have radiolabeled Serodolin, a molecule with potent analgesic properties, with carbon-11 in order to assess, using PET, its ability to bind specifically to the serotonin receptors involved in pain modulation.
Une équipe de l’I2BC développe des mimétiques de haute affinité pour la protéine ASF1. Leur combinaison de peptides et de foldamères permet de recréer fidèlement la structure et le mode de liaison du dimère H3-H4 natif sur ASF1, et d’obtenir de meilleures stabilité et perméabilité cellulaire.
Yeast Surface Display is used for antibody screening. Researchers at SIMoS have developed a version that adds developability to the selection criteria for candidate antibodies intended for therapeutic applications.
Une étude menée par une équipe de NeuroSpin montre que, lorsqu’on compare la valeur de deux nombres, le cerveau organise ces informations au sein d’une carte commune dans le sillon intrapariétal, qui s’apparente à une ligne numérique mentale. Cette carte intègre les nombres entiers, mais également les fractions au sein d’un même système, en fonction de leur valeur numérique.
A study combining molecular biology and biophysics approaches, conducted by a team at I2BC, has characterized the regions involved in the interaction between kinesin-1 and the adaptor proteins JIP3 and JIP4. The resulting mapping provides insight into how kinesin's autoinhibition could be relieved by JIP3/4.
Researchers from SIMoS demonstrate that the apelin receptor contains a disulfide bridge that differentially regulates the binding of its two known ligands and the signaling pathways dependent on them. This disulfide bridge creates a structural constraint similar to a characteristic motif of chemokine receptors involved in the migration of immune system cells.
In collaboration with Sanofi and a Spanish laboratory, researchers from the SCBM have developed a ruthenium nanocatalyst that enables the efficient and precise incorporation of deuterium or tritium into complex polar molecules and biopharmaceuticals in aqueous media.
Researchers from DMTS in collaboration with the Pasteur Institute have discovered and characterized a new toxin, ingrilimine, produced by a phytoplankton micro-organism. Its unique properties regarding a key receptor in neurodegenerative and cancer processes pave the way for the design of new therapeutic strategies.
A team from NeuroSpin and Robert Debré Hospital used EEG to monitor changes in theta oscillations in preterm and full-term infants. Using spectral analysis of the EEG, the researchers observed an increase in these periodic signals, accompanied by inter-individual variability in preterm infants, indicating greater vulnerability.
Inspired by a metalloenzyme that reduces CO₂ to CO, researchers from I2BC designed two variants of an iron-porphyrin-based catalyst that differ only in the spatial arrangement of the reactive groups in the second coordination sphere. One of these configurations achieves remarkable catalytic performance.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.